C9orf72 Protein Plasmatic Concentrations Are Similar between C9ORF72 Expansion Carriers and Noncarriers in Frontotemporal Dementia

Dement Geriatr Cogn Disord. 2018;46(3-4):180-185. doi: 10.1159/000492963. Epub 2018 Sep 27.

Abstract

Background/aims: The aim of the study was to assess the theory of haploinsufficiency in C9ORF72 expansion carriers, the most frequent causative gene of frontotemporal dementia.

Methods: Plasmatic concentrations of C9orf72 protein were measured in 33 patients suspected of familial frontotemporal dementia using an enzyme-linked immunosorbent assay.

Results: No difference was observed between C9ORF72 expansion carriers (21.2% of patients) and noncarriers (78.8% of patients). C9orf72 protein determination is not a suitable biomarker for screening C9ORF72 expansion carriers.

Conclusion: Our results provide new evidence against the hypothesis of haploinsufficiency leading to frontotemporal dementia in C9ORF72 expansion carriers.

Keywords: C9ORF72 expansion; C9orf72 protein; Frontotemporal dementia; Haploinsufficiency.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • C9orf72 Protein* / blood
  • C9orf72 Protein* / genetics
  • Correlation of Data
  • DNA Repeat Expansion
  • Female
  • France
  • Frontotemporal Dementia* / blood
  • Frontotemporal Dementia* / genetics
  • Humans
  • Male
  • Middle Aged

Substances

  • C9orf72 Protein